MedPath

Phase I/II trial of cisplatin-based transarterial infusion and concomitant radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis

Not Applicable
Conditions
Hepatocellular carcinoma with portal vein tumor thrombosis
Registration Number
JPRN-UMIN000006822
Lead Sponsor
kobe University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
48
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who have received platinum based anti cancer drug prior to the initiation of study treatment extrahepatic metastasis HCC with severe hepatic vein and biliary tumor thrombosis Untreated esophageal and gastric varices with red color signs stage II-IV encephalopathy Allergic to a contrast media and platinum Severe complications such as interstitial pneumonia, DM, heart failure, lung failure and liver failure Active infection Other cancers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath